{
    "abstract": "Introduction We compared co-administration versus separate administration of an inactivated quadrivalent influenza vaccine (IIV4) with a 23-valent pneumococcal polysaccharide vaccine (PPV23) in adults at high risk of complications of influenza and pneumococcal infection. Methods This phase III, placebo-controlled, observer-blind trial (NCT02218697) was conducted in France and Belgium during the 2014\u20132015 influenza season. Adults \u226550 years of age meeting their country's vaccination recommendations were randomized 1:1 to co-administration or separate administration. Immunogenicity was assessed by hemagglutination inhibition (HI) titers for IIV4 and 22F-inhibition ELISA for PPV23. Co-primary objectives were to demonstrate non-inferiority of co-administration versus separate administration in terms of geometric mean titer (GMT) ratio for each influenza strain in the IIV4 and geometric mean concentration (GMC) ratio for six pneumococcal serotypes (1, 3, 4, 7F, 14, 19A) in the PPV23 in the per-protocol cohort (N = 334). Results The study met its co-primary objectives, with the upper limit of the 95% confidence interval of the GMT and GMC ratios (separate administration over co-administration) being \u22642.0 for all four antigens of the IIV4 and the six pre-selected serotypes of the PPV23, respectively. Immunogenicity of the IIV4 and PPV23 was similar regardless of administration schedule. In a post hoc analysis pooling participants \u226560 years of age from the co-administration and separate administration groups, IIV4 immunogenicity was similar in higher risk adults with comorbidities (diabetes; respiratory, heart, kidney, liver, or neurological diseases; morbid obesity) versus those without. Both vaccines had an acceptable safety and reactogenicity profile; pain was the most common symptom, occurring more often with co-administration than separate administration. Conclusion The IIV4 and PPV23 can be co-administered without reducing antibody responses reflecting protection against influenza or pneumococcal disease. Co-administration of PPV23 at the annual influenza vaccination visit may improve uptake. Comorbidities had no impact on IIV4 immunogenicity, supporting its value in older adults with chronic medical conditions. Clinical Trial Registry Number: NCT02218697.",
    "author_highlights": [
        {
            "endOffset": 14501,
            "sentence": "Co-administration of IIV4 with PPV23 was compared with separate administration.",
            "startOffset": 14422
        },
        {
            "endOffset": 14582,
            "sentence": "Immunological non-inferiority of co-administration was shown for IIV4 and PPV23.",
            "startOffset": 14502
        },
        {
            "endOffset": 14649,
            "sentence": "Both vaccines had an acceptable safety and reactogenicity profile.",
            "startOffset": 14583
        },
        {
            "endOffset": 14732,
            "sentence": "Co-administration of PPV23 at annual influenza vaccination visits may help uptake.",
            "startOffset": 14650
        },
        {
            "endOffset": 14794,
            "sentence": "High-risk comorbidities had no impact on IIV4 immunogenicity.",
            "startOffset": 14733
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Zhou"
                },
                {
                    "first": "William W.",
                    "initial": "W.W.",
                    "last": "Thompson"
                },
                {
                    "first": "Cecile G.",
                    "initial": "C.G.",
                    "last": "Viboud"
                },
                {
                    "first": "Corinne M.",
                    "initial": "C.M.",
                    "last": "Ringholz"
                },
                {
                    "first": "Po Yung",
                    "initial": "P.Y.",
                    "last": "Cheng"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Steiner"
                },
                {
                    "first": "Glen R.",
                    "initial": "G.R.",
                    "last": "Abedi"
                },
                {
                    "first": "Larry J.",
                    "initial": "L.J.",
                    "last": "Anderson"
                },
                {
                    "first": "Lynnette",
                    "initial": "L.",
                    "last": "Brammer"
                },
                {
                    "first": "David K.",
                    "initial": "D.K.",
                    "last": "Shay"
                }
            ],
            "doi": "10.1093/cid/cis211",
            "firstpage": "1427",
            "issn": "10584838",
            "lastpage": "1436",
            "pmid": "22495079",
            "pub_year": 2012,
            "title": "Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008",
            "volume": "54"
        },
        "b0010": {
            "authors": [
                {
                    "first": "William W.",
                    "initial": "W.W.",
                    "last": "Thompson"
                },
                {
                    "first": "David K.",
                    "initial": "D.K.",
                    "last": "Shay"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Weintraub"
                },
                {
                    "first": "Lynnette",
                    "initial": "L.",
                    "last": "Brammer"
                },
                {
                    "first": "Carolyn B.",
                    "initial": "C.B.",
                    "last": "Bridges"
                },
                {
                    "first": "Nancy J.",
                    "initial": "N.J.",
                    "last": "Cox"
                },
                {
                    "first": "Keiji",
                    "initial": "K.",
                    "last": "Fukuda"
                }
            ],
            "doi": "10.1001/jama.292.11.1333",
            "firstpage": "1333",
            "issn": "00987484",
            "lastpage": "1340",
            "pmid": "15367555",
            "pub_year": 2004,
            "title": "Influenza-associated hospitalizations in the United States",
            "volume": "292"
        },
        "b0015": {
            "authors": [
                {
                    "first": "William W.",
                    "initial": "W.W.",
                    "last": "Thompson"
                },
                {
                    "first": "David K.",
                    "initial": "D.K.",
                    "last": "Shay"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Weintraub"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Cox"
                },
                {
                    "first": "Larry J.",
                    "initial": "L.J.",
                    "last": "Anderson"
                },
                {
                    "first": "Keiji",
                    "initial": "K.",
                    "last": "Fukuda"
                }
            ],
            "doi": "10.1001/jama.289.2.179",
            "firstpage": "179",
            "issn": "00987484",
            "lastpage": "186",
            "pmid": "12517228",
            "pub_year": 2003,
            "title": "Mortality associated with influenza and respiratory syncytial virus in the United States",
            "volume": "289"
        },
        "b0020": null,
        "b0025": {
            "authors": [
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Ryan"
                },
                {
                    "first": "York",
                    "initial": "Y.",
                    "last": "Zoellner"
                },
                {
                    "first": "Birgit",
                    "initial": "B.",
                    "last": "Gradl"
                },
                {
                    "first": "Bram",
                    "initial": "B.",
                    "last": "Palache"
                },
                {
                    "first": "Jeroen",
                    "initial": "J.",
                    "last": "Medema"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.07.042",
            "firstpage": "6812",
            "issn": "0264410X",
            "lastpage": "6822",
            "pmid": "17034909",
            "pub_year": 2006,
            "title": "Establishing the health and economic impact of influenza vaccination within the European Union 25 countries",
            "volume": "24"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Talia M.",
                    "initial": "T.M.",
                    "last": "Quandelacy"
                },
                {
                    "first": "Cecile",
                    "initial": "C.",
                    "last": "Viboud"
                },
                {
                    "first": "Vivek",
                    "initial": "V.",
                    "last": "Charu"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Lipsitch"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Goldstein"
                }
            ],
            "doi": "10.1093/aje/kwt235",
            "firstpage": "157",
            "issn": "00029262",
            "lastpage": "167",
            "pmid": "24190951",
            "pub_year": 2014,
            "title": "Age- and sex-related risk factors for influenza-associated mortality in the United States between 1997-2007",
            "volume": "179"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Maria D.",
                    "initial": "M.D.",
                    "last": "Van Kerkhove"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Cooper"
                },
                {
                    "first": "Angelia A.",
                    "initial": "A.A.",
                    "last": "Cost"
                },
                {
                    "first": "Jose L.",
                    "initial": "J.L.",
                    "last": "Sanchez"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Riley"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.09.115",
            "firstpage": "6970",
            "issn": "0264410X",
            "lastpage": "6976",
            "pmid": "26494627",
            "pub_year": 2015,
            "title": "Risk factors for severe outcomes among members of the United States military hospitalized with pneumonia and influenza, 2000-2012",
            "volume": "33"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Shikha",
                    "initial": "S.",
                    "last": "Garg"
                },
                {
                    "first": "Seema",
                    "initial": "S.",
                    "last": "Jain"
                },
                {
                    "first": "Fatimah S.",
                    "initial": "F.S.",
                    "last": "Dawood"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Jhung"
                },
                {
                    "first": "Alejandro",
                    "initial": "A.",
                    "last": "P\u00e9rez"
                },
                {
                    "first": "Tiffany",
                    "initial": "T.",
                    "last": "D'Mello"
                },
                {
                    "first": "Arthur",
                    "initial": "A.",
                    "last": "Reingold"
                },
                {
                    "first": "Ken",
                    "initial": "K.",
                    "last": "Gershman"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Meek"
                },
                {
                    "first": "Kathryn E.",
                    "initial": "K.E.",
                    "last": "Arnold"
                },
                {
                    "first": "Monica M.",
                    "initial": "M.M.",
                    "last": "Farley"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Ryan"
                },
                {
                    "first": "Ruth",
                    "initial": "R.",
                    "last": "Lynfield"
                },
                {
                    "first": "Craig",
                    "initial": "C.",
                    "last": "Morin"
                },
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "Baumbach"
                },
                {
                    "first": "Emily B.",
                    "initial": "E.B.",
                    "last": "Hancock"
                },
                {
                    "first": "Shelley",
                    "initial": "S.",
                    "last": "Zansky"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Bennett"
                },
                {
                    "first": "Ann",
                    "initial": "A.",
                    "last": "Thomas"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Schaffner"
                },
                {
                    "first": "Lyn",
                    "initial": "L.",
                    "last": "Finelli"
                }
            ],
            "doi": "10.1186/s12879-015-1004-y",
            "issn": "14712334",
            "pmid": "26307108",
            "pub_year": 2015,
            "title": "Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005-2008",
            "volume": "15"
        },
        "b0045": null,
        "b0050": {
            "authors": [
                {
                    "first": "Haley J.",
                    "initial": "H.J.",
                    "last": "Morrill"
                },
                {
                    "first": "Aisling R.",
                    "initial": "A.R.",
                    "last": "Caffrey"
                },
                {
                    "first": "Eunsun",
                    "initial": "E.",
                    "last": "Noh"
                },
                {
                    "first": "Kerry L.",
                    "initial": "K.L.",
                    "last": "LaPlante"
                }
            ],
            "doi": "10.1007/s40121-014-0025-y",
            "firstpage": "19",
            "issn": "21938229",
            "lastpage": "33",
            "pub_year": 2014,
            "title": "Epidemiology of Pneumococcal Disease in a National Cohort of Older Adults",
            "volume": "3"
        },
        "b0055": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Verhaegen"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Flamaing"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "De Backer"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Delaere"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Van Herck"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Surmont"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Van Laethem"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Peetermans"
                }
            ],
            "issn": "1025496X",
            "pmid": "600010433",
            "pub_year": 2014,
            "title": "Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009\u20132011"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Gertjan H.J.",
                    "initial": "G.H.J.",
                    "last": "Wagenvoort"
                },
                {
                    "first": "Mirjam J.",
                    "initial": "M.J.",
                    "last": "Knol"
                },
                {
                    "first": "Hester E.",
                    "initial": "H.E.",
                    "last": "de Melker"
                },
                {
                    "first": "Bart J.",
                    "initial": "B.J.",
                    "last": "Vlaminckx"
                },
                {
                    "first": "Arie",
                    "initial": "A.",
                    "last": "van der Ende"
                },
                {
                    "first": "Mark H.",
                    "initial": "M.H.",
                    "last": "Rozenbaum"
                },
                {
                    "first": "Elisabeth A.M.",
                    "initial": "E.A.M.",
                    "last": "Sanders"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.11.048",
            "firstpage": "334",
            "issn": "0264410X",
            "lastpage": "340",
            "pmid": "26647289",
            "pub_year": 2016,
            "title": "Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands",
            "volume": "34"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Maartje",
                    "initial": "M.",
                    "last": "Kristensen"
                },
                {
                    "first": "Alies",
                    "initial": "A.",
                    "last": "Van Lier"
                },
                {
                    "first": "Renske",
                    "initial": "R.",
                    "last": "Eilers"
                },
                {
                    "first": "Scott A.",
                    "initial": "S.A.",
                    "last": "McDonald"
                },
                {
                    "first": "Wim",
                    "initial": "W.",
                    "last": "Opstelten"
                },
                {
                    "first": "Nicoline",
                    "initial": "N.",
                    "last": "Van Der Maas"
                },
                {
                    "first": "Wim",
                    "initial": "W.",
                    "last": "Van Der Hoek"
                },
                {
                    "first": "Mirjam E.",
                    "initial": "M.E.",
                    "last": "Kretzschmar"
                },
                {
                    "first": "Mark M.",
                    "initial": "M.M.",
                    "last": "Nielen"
                },
                {
                    "first": "Hester E.",
                    "initial": "H.E.",
                    "last": "De Melker"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.12.052",
            "firstpage": "942",
            "issn": "0264410X",
            "lastpage": "949",
            "pmid": "26752065",
            "pub_year": 2016,
            "title": "Burden of four vaccine preventable diseases in older adults",
            "volume": "34"
        },
        "b0070": {
            "authors": [
                {
                    "first": "James D.",
                    "initial": "J.D.",
                    "last": "Chalmers"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Campling"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Dicker"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Woodhead"
                },
                {
                    "first": "Harish",
                    "initial": "H.",
                    "last": "Madhava"
                }
            ],
            "doi": "10.1186/s12890-016-0242-0",
            "issn": "14712466",
            "pmid": "27169895",
            "pub_year": 2016,
            "title": "A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults",
            "volume": "16"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Albert Jan",
                    "initial": "A.J.",
                    "last": "van Hoek"
                },
                {
                    "first": "Nick",
                    "initial": "N.",
                    "last": "Andrews"
                },
                {
                    "first": "Pauline A.",
                    "initial": "P.A.",
                    "last": "Waight"
                },
                {
                    "first": "Julia",
                    "initial": "J.",
                    "last": "Stowe"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Gates"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "George"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1016/j.jinf.2012.02.017",
            "firstpage": "17",
            "issn": "01634453",
            "lastpage": "24",
            "pmid": "22394683",
            "pub_year": 2012,
            "title": "The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England",
            "volume": "65"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Moe H.",
                    "initial": "M.H.",
                    "last": "Kyaw"
                },
                {
                    "first": "Charles E.",
                    "initial": "C.E.",
                    "last": "Rose"
                },
                {
                    "first": "Alicia M.",
                    "initial": "A.M.",
                    "last": "Fry"
                },
                {
                    "first": "James A.",
                    "initial": "J.A.",
                    "last": "Singleton"
                },
                {
                    "first": "Zack",
                    "initial": "Z.",
                    "last": "Moore"
                },
                {
                    "first": "Elizabeth R.",
                    "initial": "E.R.",
                    "last": "Zell"
                },
                {
                    "first": "Cynthia G.",
                    "initial": "C.G.",
                    "last": "Whitney"
                }
            ],
            "doi": "10.1086/431521",
            "firstpage": "377",
            "issn": "00221899",
            "lastpage": "386",
            "pmid": "15995950",
            "pub_year": 2005,
            "title": "The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults",
            "volume": "192"
        },
        "b0085": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Nicholas D Walter"
                },
                {
                    "first": "Thomas H.",
                    "initial": "T.H.",
                    "last": "Taylor"
                },
                {
                    "first": "David K.",
                    "initial": "D.K.",
                    "last": "Shay"
                },
                {
                    "first": "William W.",
                    "initial": "W.W.",
                    "last": "Thompson"
                },
                {
                    "first": "Lynnette",
                    "initial": "L.",
                    "last": "Brammer"
                },
                {
                    "first": "Scott F.",
                    "initial": "S.F.",
                    "last": "Dowell"
                },
                {
                    "first": "Matthew R.",
                    "initial": "M.R.",
                    "last": "Moore"
                }
            ],
            "doi": "10.1086/649208",
            "firstpage": "175",
            "issn": "10584838",
            "lastpage": "183",
            "pmid": "20014948",
            "pub_year": 2010,
            "title": "Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States",
            "volume": "50"
        },
        "b0090": {
            "authors": [
                {
                    "first": "M. H.",
                    "initial": "M.H.",
                    "last": "Kyaw"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Clarke"
                },
                {
                    "first": "I. G.",
                    "initial": "I.G.",
                    "last": "Jones"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Campbell"
                }
            ],
            "doi": "10.1017/S0950268801006586",
            "firstpage": "139",
            "issn": "09502688",
            "lastpage": "147",
            "pmid": "12002530",
            "pub_year": 2002,
            "title": "Incidence of invasive pneumococcal disease in Scotland, 1988-99",
            "volume": "128"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Thomas R.",
                    "initial": "T.R.",
                    "last": "Talbot"
                },
                {
                    "first": "Katherine A.",
                    "initial": "K.A.",
                    "last": "Poehling"
                },
                {
                    "first": "Tina V.",
                    "initial": "T.V.",
                    "last": "Hartert"
                },
                {
                    "first": "Patrick G.",
                    "initial": "P.G.",
                    "last": "Arbogast"
                },
                {
                    "first": "Natasha B.",
                    "initial": "N.B.",
                    "last": "Halasa"
                },
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Edwards"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Schaffner"
                },
                {
                    "first": "Allen S.",
                    "initial": "A.S.",
                    "last": "Craig"
                },
                {
                    "first": "Marie R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                }
            ],
            "doi": "10.1016/j.amjmed.2004.09.016",
            "firstpage": "285",
            "issn": "00029343",
            "lastpage": "291",
            "pmid": "15745727",
            "pub_year": 2005,
            "title": "Seasonality of invasive pneumococcal disease: Temporal relation to documented influenza and respiratory syncytial viral circulation",
            "volume": "118"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Katarzyna",
                    "initial": "K.",
                    "last": "Grabowska"
                },
                {
                    "first": "Liselotte",
                    "initial": "L.",
                    "last": "H\u00f6gberg"
                },
                {
                    "first": "Pasi",
                    "initial": "P.",
                    "last": "Penttinen"
                },
                {
                    "first": "\u00c5ke",
                    "initial": "A.",
                    "last": "Svensson"
                },
                {
                    "first": "Karl",
                    "initial": "K.",
                    "last": "Ekdahl"
                }
            ],
            "doi": "10.1186/1471-2334-6-58",
            "issn": "14712334",
            "pmid": "16549029",
            "pub_year": 2006,
            "title": "Occurrence of invasive pneumococcal disease and number of excess cases due to influenza",
            "volume": "6"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Melinda M.",
                    "initial": "M.M.",
                    "last": "Pettigrew"
                },
                {
                    "first": "Laura R.",
                    "initial": "L.R.",
                    "last": "Marks"
                },
                {
                    "first": "Yong",
                    "initial": "Y.",
                    "last": "Kong"
                },
                {
                    "first": "Janneane F.",
                    "initial": "J.F.",
                    "last": "Gent"
                },
                {
                    "first": "Hazeline",
                    "initial": "H.",
                    "last": "Roche-Hakansson"
                },
                {
                    "first": "Anders P.",
                    "initial": "A.P.",
                    "last": "Hakansson"
                }
            ],
            "doi": "10.1128/IAI.02225-14",
            "firstpage": "4607",
            "issn": "00199567",
            "lastpage": "4619",
            "pmid": "25135685",
            "pub_year": 2014,
            "title": "Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection",
            "volume": "82"
        },
        "b0110": {
            "authors": [
                {
                    "first": "D. M.",
                    "initial": "D.M.",
                    "last": "Skowronski"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Masaro"
                },
                {
                    "first": "T. L.",
                    "initial": "T.L.",
                    "last": "Kwindt"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Mak"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Petric"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Sebastian"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Chong"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Tam"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "De Serres"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.10.002",
            "firstpage": "2842",
            "issn": "0264410X",
            "lastpage": "2851",
            "pmid": "17081662",
            "pub_year": 2007,
            "title": "Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada",
            "volume": "25"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Edward A.",
                    "initial": "E.A.",
                    "last": "Belongia"
                },
                {
                    "first": "Burney A.",
                    "initial": "B.A.",
                    "last": "Kieke"
                },
                {
                    "first": "James G.",
                    "initial": "J.G.",
                    "last": "Donahue"
                },
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Greenlee"
                },
                {
                    "first": "Amanda",
                    "initial": "A.",
                    "last": "Balish"
                },
                {
                    "first": "Angie",
                    "initial": "A.",
                    "last": "Foust"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Lindstrom"
                },
                {
                    "first": "David K.",
                    "initial": "D.K.",
                    "last": "Shay"
                }
            ],
            "doi": "10.1086/595861",
            "firstpage": "159",
            "issn": "00221899",
            "lastpage": "167",
            "pmid": "19086915",
            "pub_year": 2009,
            "title": "Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season",
            "volume": "199"
        },
        "b0120": null,
        "b0125": {
            "authors": [
                {
                    "first": "Yan Yang",
                    "initial": "Y.Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Xue Feng",
                    "initial": "X.F.",
                    "last": "Tang"
                },
                {
                    "first": "Chang Hui",
                    "initial": "C.H.",
                    "last": "Du"
                },
                {
                    "first": "Bin Bing",
                    "initial": "B.B.",
                    "last": "Wang"
                },
                {
                    "first": "Zhen Wang",
                    "initial": "Z.W.",
                    "last": "Bi"
                },
                {
                    "first": "Bi Rong",
                    "initial": "B.R.",
                    "last": "Dong"
                }
            ],
            "doi": "10.1080/21645515.2016.1221552",
            "firstpage": "3056",
            "issn": "21645515",
            "lastpage": "3064",
            "pmid": "27629584",
            "pub_year": 2016,
            "title": "Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis",
            "volume": "12"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Kristin L.",
                    "initial": "K.L.",
                    "last": "Nichol"
                }
            ],
            "doi": "10.1016/S0264-410X(99)00114-0",
            "firstpage": "S91",
            "issn": "0264410X",
            "lastpage": "S93",
            "pmid": "10471189",
            "pub_year": 1999,
            "title": "The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease",
            "volume": "17"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Dom\u00ednguez"
                },
                {
                    "first": "Jes\u00fas",
                    "initial": "J.",
                    "last": "Castilla"
                },
                {
                    "first": "Pere",
                    "initial": "P.",
                    "last": "Godoy"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "Delgado-Rodr\u00edguez"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Saez"
                },
                {
                    "first": "N\u00faria",
                    "initial": "N.",
                    "last": "Soldevila"
                },
                {
                    "first": "Jenaro",
                    "initial": "J.",
                    "last": "Astray"
                },
                {
                    "first": "Jos\u00e9 Mar\u00eda",
                    "initial": "J.M.",
                    "last": "Mayoral"
                },
                {
                    "first": "Vicente",
                    "initial": "V.",
                    "last": "Mart\u00edn"
                },
                {
                    "first": "Jos\u00e9 Mar\u00eda",
                    "initial": "J.M.",
                    "last": "Quintana"
                },
                {
                    "first": "Fernando",
                    "initial": "F.",
                    "last": "Gonz\u00e1lez-Candelas"
                },
                {
                    "first": "Juan Carlos",
                    "initial": "J.C.",
                    "last": "Gal\u00e1n"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Tamames"
                },
                {
                    "first": "Ady",
                    "initial": "A.",
                    "last": "Castro"
                },
                {
                    "first": "Maretva",
                    "initial": "M.",
                    "last": "Baricot"
                },
                {
                    "first": "Olatz",
                    "initial": "O.",
                    "last": "Gar\u00edn"
                },
                {
                    "first": "Tom\u00e1s",
                    "initial": "T.",
                    "last": "Pumarola"
                }
            ],
            "doi": "10.4161/hv.23090",
            "firstpage": "865",
            "issn": "21645515",
            "lastpage": "873",
            "pmid": "23563516",
            "pub_year": 2013,
            "title": "Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons",
            "volume": "9"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Tuen Ching",
                    "initial": "T.C.",
                    "last": "Chan"
                },
                {
                    "first": "Ivan Fan Ngai",
                    "initial": "I.F.N.",
                    "last": "Hung"
                },
                {
                    "first": "James Ka Hay",
                    "initial": "J.K.H.",
                    "last": "Luk"
                },
                {
                    "first": "Yat Fung",
                    "initial": "Y.F.",
                    "last": "Shea"
                },
                {
                    "first": "Felix Hon Wai",
                    "initial": "F.H.W.",
                    "last": "Chan"
                },
                {
                    "first": "Patrick Chiu Yat",
                    "initial": "P.C.Y.",
                    "last": "Woo"
                },
                {
                    "first": "Leung Wing",
                    "initial": "L.W.",
                    "last": "Chu"
                }
            ],
            "doi": "10.1016/j.jamda.2012.05.009",
            "firstpage": "698",
            "issn": "15258610",
            "lastpage": "703",
            "pmid": "22722051",
            "pub_year": 2012,
            "title": "Prevention of Mortality and Pneumonia Among Nursing Home Older Adults by Dual Pneumococcal and Seasonal Influenza Vaccination During a Pandemic Caused by Novel Pandemic Influenza A (H1N1)",
            "volume": "13"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Coralie",
                    "initial": "C.",
                    "last": "Giese"
                },
                {
                    "first": "Jolita",
                    "initial": "J.",
                    "last": "Mereckiene"
                },
                {
                    "first": "Kostas",
                    "initial": "K.",
                    "last": "Danis"
                },
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "O'Donnell"
                },
                {
                    "first": "Darina",
                    "initial": "D.",
                    "last": "O'Flanagan"
                },
                {
                    "first": "Suzanne",
                    "initial": "S.",
                    "last": "Cotter"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.05.028",
            "firstpage": "3657",
            "issn": "0264410X",
            "lastpage": "3662",
            "pmid": "27255466",
            "pub_year": 2016,
            "title": "Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination",
            "volume": "34"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Ihsane",
                    "initial": "I.",
                    "last": "Hmamouchi"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Winthrop"
                },
                {
                    "first": "Odile",
                    "initial": "O.",
                    "last": "Launay"
                },
                {
                    "first": "Maxime",
                    "initial": "M.",
                    "last": "Dougados"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.01.065",
            "firstpage": "1446",
            "issn": "0264410X",
            "lastpage": "1452",
            "pmid": "25659279",
            "pub_year": 2015,
            "title": "Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: Data from the international COMORA cohort",
            "volume": "33"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Maria A.",
                    "initial": "M.A.",
                    "last": "Villarroel"
                },
                {
                    "first": "Anjel",
                    "initial": "A.",
                    "last": "Vahratian"
                }
            ],
            "firstpage": "1",
            "issn": "19414927",
            "lastpage": "8",
            "pmid": "27930282",
            "pub_year": 2016,
            "title": "Vaccination Coverage Among Adults With Diagnosed Diabetes: United States, 2015"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Florent",
                    "initial": "F.",
                    "last": "Valour"
                },
                {
                    "first": "Laurent",
                    "initial": "L.",
                    "last": "Cotte"
                },
                {
                    "first": "Nicolas",
                    "initial": "N.",
                    "last": "Voirin"
                },
                {
                    "first": "Matthieu",
                    "initial": "M.",
                    "last": "Godinot"
                },
                {
                    "first": "Florence",
                    "initial": "F.",
                    "last": "Ader"
                },
                {
                    "first": "Tristan",
                    "initial": "T.",
                    "last": "Ferry"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Vanhems"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Chidiac"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.06.015",
            "firstpage": "4558",
            "issn": "0264410X",
            "lastpage": "4564",
            "pmid": "24951870",
            "pub_year": 2014,
            "title": "Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients",
            "volume": "32"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Loubet"
                },
                {
                    "first": "Solen",
                    "initial": "S.",
                    "last": "Kern\u00e9is"
                },
                {
                    "first": "Matthieu",
                    "initial": "M.",
                    "last": "Groh"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Loulergue"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Blanche"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Verger"
                },
                {
                    "first": "Odile",
                    "initial": "O.",
                    "last": "Launay"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.06.012",
            "firstpage": "3703",
            "issn": "0264410X",
            "lastpage": "3708",
            "pmid": "26073016",
            "pub_year": 2015,
            "title": "Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency",
            "volume": "33"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Linda M.",
                    "initial": "L.M.",
                    "last": "Kaljee"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Kilgore"
                },
                {
                    "first": "Tyler",
                    "initial": "T.",
                    "last": "Prentiss"
                },
                {
                    "first": "Lois",
                    "initial": "L.",
                    "last": "Lamerato"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Moreno"
                },
                {
                    "first": "Samia",
                    "initial": "S.",
                    "last": "Arshad"
                },
                {
                    "first": "Marcus",
                    "initial": "M.",
                    "last": "Zervos"
                }
            ],
            "doi": "10.1080/21645515.2016.1228503",
            "firstpage": "206",
            "issn": "21645515",
            "lastpage": "212",
            "pmid": "27625007",
            "pub_year": 2017,
            "title": "\u201cYou need to be an advocate for yourself\u201d: Factors associated with decision-making regarding influenza and pneumococcal vaccine use among US older adults from within a large metropolitan health system",
            "volume": "13"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Shawn A.N.",
                    "initial": "S.A.N.",
                    "last": "Gilchrist"
                },
                {
                    "first": "Angeline",
                    "initial": "A.",
                    "last": "Nanni"
                },
                {
                    "first": "Orin",
                    "initial": "O.",
                    "last": "Levine"
                }
            ],
            "doi": "10.2105/AJPH.2011.300512",
            "firstpage": "596",
            "issn": "00900036",
            "lastpage": "605",
            "pmid": "22397339",
            "pub_year": 2012,
            "title": "Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: An approach for policymakers",
            "volume": "102"
        },
        "b0180": {
            "authors": [
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Fletcher"
                },
                {
                    "first": "W. S.",
                    "initial": "W.S.",
                    "last": "Tunnicliffe"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Hammond"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Roberts"
                },
                {
                    "first": "J. G.",
                    "initial": "J.G.",
                    "last": "Ayres"
                }
            ],
            "firstpage": "1663",
            "issn": "09598146",
            "lastpage": "1665",
            "pmid": "9193290",
            "pub_year": 1997,
            "title": "Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease",
            "volume": "314"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Joon Young",
                    "initial": "J.Y.",
                    "last": "Song"
                },
                {
                    "first": "Hee Jin",
                    "initial": "H.J.",
                    "last": "Cheong"
                },
                {
                    "first": "T. F.",
                    "initial": "T.F.",
                    "last": "Tsai"
                },
                {
                    "first": "Hyun ah",
                    "initial": "H.a.",
                    "last": "Chang"
                },
                {
                    "first": "Min Joo",
                    "initial": "M.J.",
                    "last": "Choi"
                },
                {
                    "first": "Ji Ho",
                    "initial": "J.H.",
                    "last": "Jeon"
                },
                {
                    "first": "Seong Hee",
                    "initial": "S.H.",
                    "last": "Kang"
                },
                {
                    "first": "Eun Ju",
                    "initial": "E.J.",
                    "last": "Jeong"
                },
                {
                    "first": "Ji Yun",
                    "initial": "J.Y.",
                    "last": "Noh"
                },
                {
                    "first": "Woo Joo",
                    "initial": "W.J.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.05.003",
            "firstpage": "4647",
            "issn": "0264410X",
            "lastpage": "4652",
            "pmid": "25980426",
            "pub_year": 2015,
            "title": "Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults",
            "volume": "33"
        },
        "b0190": {
            "authors": [
                {
                    "first": "T. F.",
                    "initial": "T.F.",
                    "last": "Schwarz"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Flamaing"
                },
                {
                    "first": "H. C.",
                    "initial": "H.C.",
                    "last": "R\u00fcmke"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Penzes"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Juergens"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Wenz"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Jayawardene"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Giardina"
                },
                {
                    "first": "E. A.",
                    "initial": "E.A.",
                    "last": "Emini"
                },
                {
                    "first": "W. C.",
                    "initial": "W.C.",
                    "last": "Gruber"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Schmoele-Thoma"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.05.031",
            "firstpage": "5195",
            "issn": "0264410X",
            "lastpage": "5202",
            "pmid": "21619909",
            "pub_year": 2011,
            "title": "A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged \u226565 years",
            "volume": "29"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Robert W.",
                    "initial": "R.W.",
                    "last": "Frenck"
                },
                {
                    "first": "Alejandra",
                    "initial": "A.",
                    "last": "Gurtman"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Rubino"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Smith"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Van Cleeff"
                },
                {
                    "first": "Deepthi",
                    "initial": "D.",
                    "last": "Jayawardene"
                },
                {
                    "first": "Peter C.",
                    "initial": "P.C.",
                    "last": "Giardina"
                },
                {
                    "first": "Emilio A.",
                    "initial": "E.A.",
                    "last": "Emini"
                },
                {
                    "first": "William C.",
                    "initial": "W.C.",
                    "last": "Gruber"
                },
                {
                    "first": "Daniel A.",
                    "initial": "D.A.",
                    "last": "Scott"
                },
                {
                    "first": "Beate",
                    "initial": "B.",
                    "last": "Schm\u00f6le-Thomag"
                }
            ],
            "doi": "10.1128/CVI.00176-12",
            "firstpage": "1296",
            "issn": "15566811",
            "lastpage": "1303",
            "pmid": "22739693",
            "pub_year": 2012,
            "title": "Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults",
            "volume": "19"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Karthik D.",
                    "initial": "K.D.",
                    "last": "Nath"
                },
                {
                    "first": "Julie G.",
                    "initial": "J.G.",
                    "last": "Burel"
                },
                {
                    "first": "Viswanathan",
                    "initial": "V.",
                    "last": "Shankar"
                },
                {
                    "first": "Antony L.",
                    "initial": "A.L.",
                    "last": "Pritchard"
                },
                {
                    "first": "Michelle",
                    "initial": "M.",
                    "last": "Towers"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Looke"
                },
                {
                    "first": "Janet M.",
                    "initial": "J.M.",
                    "last": "Davies"
                },
                {
                    "first": "John W.",
                    "initial": "J.W.",
                    "last": "Upham"
                }
            ],
            "doi": "10.2147/COPD.S53590",
            "firstpage": "51",
            "issn": "11769106",
            "lastpage": "56",
            "pmid": "24399872",
            "pub_year": 2014,
            "title": "Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease",
            "volume": "9"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Emily A.",
                    "initial": "E.A.",
                    "last": "Blumberg"
                },
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Albano"
                },
                {
                    "first": "Timothy",
                    "initial": "T.",
                    "last": "Pruett"
                },
                {
                    "first": "Ross",
                    "initial": "R.",
                    "last": "Isaacs"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Fitzpatrick"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Bergin"
                },
                {
                    "first": "Carolyn",
                    "initial": "C.",
                    "last": "Crump"
                },
                {
                    "first": "Frederick G.",
                    "initial": "F.G.",
                    "last": "Hayden"
                }
            ],
            "doi": "10.1093/clinids/22.2.295",
            "firstpage": "295",
            "issn": "10584838",
            "lastpage": "302",
            "pmid": "8838186",
            "pub_year": 1996,
            "title": "The immunogenicity of influenza virus vaccine in solid organ transplant recipients",
            "volume": "22"
        },
        "b0210": {
            "authors": [
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Dorrell"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Hassan"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Marshall"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Chakraverty"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Ong"
                }
            ],
            "doi": "10.1258/0956462971919264",
            "firstpage": "776",
            "issn": "09564624",
            "lastpage": "779",
            "pmid": "9433953",
            "pub_year": 1997,
            "title": "Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers",
            "volume": "8"
        }
    },
    "body_text": [
        {
            "endOffset": 22423,
            "parents": [],
            "secId": "s0010",
            "sentence": "The trial was approved by independent ethics committees or institutional review boards, conducted in accordance with the Declaration of Helsinki, the International Conference on Harmonisation Good Clinical Practice (ICH-GCP) guidelines, and regulatory requirements of participating countries.",
            "startOffset": 22131,
            "title": "Methods"
        },
        {
            "endOffset": 24565,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "A saline placebo was used.",
            "startOffset": 24539,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 28051,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "A post hoc analysis evaluated immunogenicity of the IIV4 in participants with comorbidities (diabetes; respiratory, heart, kidney, liver, or neurological diseases; morbid obesity) versus those without in a pooled co-administration/control group of participants \u226560 years of age who were considered higher-risk older adults.",
            "startOffset": 27728,
            "title": "Study objectives"
        },
        {
            "endOffset": 22471,
            "parents": [],
            "secId": "s0010",
            "sentence": "Participants provided written informed consent.",
            "startOffset": 22424,
            "title": "Methods"
        },
        {
            "endOffset": 31609,
            "parents": [],
            "secId": "s0050",
            "sentence": "Our study assessed a population of mainly older adults, most of whom had comorbidities such as chronic heart disease, chronic respiratory disease and diabetes and were therefore at higher risk of infection or complications of influenza or pneumococcal disease.",
            "startOffset": 31349,
            "title": "Discussion"
        },
        {
            "endOffset": 24960,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The assay cut-off for HI was 1:10.",
            "startOffset": 24926,
            "title": "Study endpoints"
        },
        {
            "endOffset": 25324,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "SPR was defined as the percentage of participants who attained reciprocal HI titers of \u22651:40.",
            "startOffset": 25231,
            "title": "Study endpoints"
        },
        {
            "endOffset": 35074,
            "parents": [],
            "secId": "s0050",
            "sentence": "Our study recruited participants eligible for influenza and pneumococcal vaccination under Belgian and French public health recommendations i.e. people with comorbidities that increase their risk of infection and those \u226565 years of age.",
            "startOffset": 34838,
            "title": "Discussion"
        },
        {
            "endOffset": 29224,
            "parents": [],
            "secId": "s0035",
            "sentence": "Participants with no comorbidities were approximately 8 years older than participants with one or more comorbidities; in those \u226560 years of age, the difference was approximately 5 years (Table S2).",
            "startOffset": 29027,
            "title": "Results"
        },
        {
            "endOffset": 23804,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The co-administration group received IIV4 plus PPV23 on Day 0 and placebo on Day 28; the control group received IIV4 plus placebo on Day 0 and PPV23 on Day 28.",
            "startOffset": 23645,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 35527,
            "parents": [],
            "secId": "s0050",
            "sentence": "In participants with one or two comorbidities, immunogenicity was similar regardless of administration schedule.",
            "startOffset": 35415,
            "title": "Discussion"
        },
        {
            "endOffset": 18812,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 18811,
                    "startOffset": 18808
                }
            },
            "secId": "s0005",
            "sentence": "Streptococcus pneumoniae (pneumococcus) may intermittently colonize the upper respiratory tract, from where it may cause a variety of diseases such as bacteraemia, meningitis, pneumonia, otitis media and sinusitis, with pneumonia being the most common clinical manifestation in adults [9].",
            "startOffset": 18523,
            "title": "Introduction"
        },
        {
            "endOffset": 26220,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Participants recorded solicited injection site and general symptoms on the day of vaccination and for the next 6 days (see Supplement).",
            "startOffset": 26085,
            "title": "Study endpoints"
        },
        {
            "endOffset": 27028,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 27027,
                    "startOffset": 27023
                }
            },
            "secId": "s0025",
            "sentence": "These six serotypes were selected because they are reported as leading causes of IPD in Europe [24].",
            "startOffset": 26928,
            "title": "Study objectives"
        },
        {
            "endOffset": 32777,
            "parents": [],
            "secId": "s0050",
            "sentence": "We also evaluated immunogenicity of the IIV4 according to age group, and found that it was similar regardless of whether it was co-administered with the PPV23 or administered separately in participants 50 to <60 years of age and older adults \u226560 years of age.",
            "startOffset": 32518,
            "title": "Discussion"
        },
        {
            "endOffset": 34838,
            "parents": [],
            "secId": "s0050",
            "sentence": "Overall, however, both studies demonstrated no clinically important differences in immunogenicity of the TIV or PCV13 with concomitant versus separate administration.",
            "startOffset": 34672,
            "title": "Discussion"
        },
        {
            "endOffset": 31176,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "All other injection site symptoms occurred at a low rate, similar in both study groups.",
            "startOffset": 31089,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 21553,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 21552,
                    "startOffset": 21545
                },
                "b0150": {
                    "endOffset": 21552,
                    "startOffset": 21545
                },
                "b0155": {
                    "endOffset": 21552,
                    "startOffset": 21545
                },
                "b0160": {
                    "endOffset": 21552,
                    "startOffset": 21545
                },
                "b0165": {
                    "endOffset": 21552,
                    "startOffset": 21545
                },
                "b0170": {
                    "endOffset": 21552,
                    "startOffset": 21545
                }
            },
            "secId": "s0005",
            "sentence": "However, vaccine coverage does not reach recommended levels, especially for the pneumococcal vaccine [29\u201334].",
            "startOffset": 21444,
            "title": "Introduction"
        },
        {
            "endOffset": 20465,
            "parents": [],
            "secId": "s0005",
            "sentence": "A 23-valent pneumococcal polysaccharide vaccine (PPV23) has been available since 1983 and is widely used in vaccination programs.",
            "startOffset": 20336,
            "title": "Introduction"
        },
        {
            "endOffset": 32517,
            "parents": [],
            "secId": "s0050",
            "sentence": "With regard to the secondary objectives, all estimated immunogenicity parameters for all four influenza vaccine strains and all 12 pneumococcal serotypes evaluated were similar with co-administration and separate administration.",
            "startOffset": 32289,
            "title": "Discussion"
        },
        {
            "endOffset": 18308,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 18307,
                    "startOffset": 18302
                },
                "b0010": {
                    "endOffset": 18307,
                    "startOffset": 18302
                },
                "b0015": {
                    "endOffset": 18307,
                    "startOffset": 18302
                },
                "b0020": {
                    "endOffset": 18307,
                    "startOffset": 18302
                },
                "b0025": {
                    "endOffset": 18307,
                    "startOffset": 18302
                }
            },
            "secId": "s0005",
            "sentence": "Influenza illness is an important cause of outpatient visits, hospitalization and death, with substantial associated costs [1\u20135].",
            "startOffset": 18179,
            "title": "Introduction"
        },
        {
            "endOffset": 26299,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Spontaneously reported symptoms were recorded until 28 days after vaccination.",
            "startOffset": 26221,
            "title": "Study endpoints"
        },
        {
            "endOffset": 30820,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Overall, the co-administration and control groups had a comparable incidence of injection site and general solicited symptoms, with the exception of injection site pain.",
            "startOffset": 30651,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 29026,
            "parents": [],
            "secId": "s0035",
            "sentence": "Most participants had received an influenza vaccination in the previous three seasons (75.6%) and had at least one comorbidity (85.1%) (Table S1).",
            "startOffset": 28880,
            "title": "Results"
        },
        {
            "endOffset": 37078,
            "parents": [],
            "secId": "s0050",
            "sentence": "Fatigue and muscle aches were the most common solicited symptoms during the 7-day post-vaccination period.",
            "startOffset": 36972,
            "title": "Discussion"
        },
        {
            "endOffset": 21127,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 21126,
                    "startOffset": 21119
                },
                "b0130": {
                    "endOffset": 21126,
                    "startOffset": 21119
                },
                "b0135": {
                    "endOffset": 21126,
                    "startOffset": 21119
                },
                "b0140": {
                    "endOffset": 21126,
                    "startOffset": 21119
                }
            },
            "secId": "s0005",
            "sentence": "Several studies have demonstrated that dual pneumococcal and influenza vaccination is associated with greater benefits in terms of hospitalization and mortality compared with either vaccine given alone [25\u201328].",
            "startOffset": 20917,
            "title": "Introduction"
        },
        {
            "endOffset": 30133,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "The PPV23 was also immunogenic against all 12 vaccine serotypes that were evaluated and there were no differences in the immune response between study groups (Fig. 3; Table S4).",
            "startOffset": 29956,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 20022,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, two antigenically distinct lineages of influenza B, Yamagata and Victoria, have co-circulated since 2000.",
            "startOffset": 19908,
            "title": "Introduction"
        },
        {
            "endOffset": 38118,
            "parents": [],
            "secId": "s0050",
            "sentence": "An important limitation was the high level of seropositivity for anti-influenza and anti-pneumococcal antibodies before vaccination, which impacted endpoints reflecting fold-change between pre- and post-vaccination.",
            "startOffset": 37903,
            "title": "Discussion"
        },
        {
            "endOffset": 37552,
            "parents": [],
            "secId": "s0050",
            "sentence": "The study had both strengths and limitations.",
            "startOffset": 37507,
            "title": "Discussion"
        },
        {
            "endOffset": 32965,
            "parents": [],
            "secId": "s0050",
            "sentence": "Several studies have evaluated the immunogenicity of a TIV and either a PPV23 or a PCV13 when administered concomitantly or separately.",
            "startOffset": 32830,
            "title": "Discussion"
        },
        {
            "endOffset": 29557,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "The study met its co-primary objectives by demonstrating non-inferiority of the immune response to both IIV4 and PPV23 with co-administration versus separate administration, with the upper limit of the 95% CI being \u22642.0 for the GMT and GMC ratios (control over co-administration) for all antigens evaluated (Fig. 1).",
            "startOffset": 29241,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 33542,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 33541,
                    "startOffset": 33537
                }
            },
            "secId": "s0050",
            "sentence": "In a 4-group study of MF59-adjuvanted TIV and PPV23 (TIV alone, TIV plus PPV23 administered in the same arm, TIV plus PPV23 administered in different arms, and PPV23 alone) in adults \u226565 years of age, there was a similar immune response to influenza and pneumococcal (5, 6B, 18C and 19A) antigens regardless of concomitant vaccination [37].",
            "startOffset": 33202,
            "title": "Discussion"
        },
        {
            "endOffset": 22908,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Investigators recorded comorbidities present at baseline using a checklist (see categories in Table S1).",
            "startOffset": 22804,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 23143,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The randomization sequence was generated at GSK using MATerial Excellence (MATEX), a program developed by GSK for use in SAS.",
            "startOffset": 23018,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 36203,
            "parents": [],
            "secId": "s0050",
            "sentence": "It should be noted that participants \u226560 years of age with no comorbidities were approximately 4\u20135 years older than participants with comorbidities, which may have helped to balance out any impact of comorbidities on the robustness of the immune response.",
            "startOffset": 35948,
            "title": "Discussion"
        },
        {
            "endOffset": 36560,
            "parents": [],
            "secId": "s0050",
            "sentence": "Overall, however, the data suggest that the immune response to the IIV4 is similar regardless of comorbidities, and, indeed, support the value of administering IIV4 to individuals \u226560 years of age with common chronic medical conditions such as heart disease, respiratory disease and diabetes that place them at increased risk for complications of influenza.",
            "startOffset": 36203,
            "title": "Discussion"
        },
        {
            "endOffset": 33746,
            "parents": [],
            "secId": "s0050",
            "sentence": "In contrast to these data for PPV23, there is some evidence of a lower immune response with the PCV13 for some pneumococcal serotypes when co-administered with a TIV compared with separate administration.",
            "startOffset": 33542,
            "title": "Discussion"
        },
        {
            "endOffset": 32830,
            "parents": [],
            "secId": "s0050",
            "sentence": "As expected, GMTs were lower in the older age group.",
            "startOffset": 32778,
            "title": "Discussion"
        },
        {
            "endOffset": 26927,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The co-primary objectives were to demonstrate immunologic non-inferiority of co-administration versus separate administration of the IIV4 and PPV23 in terms of: (1) immune response measured by HI antibody titer for each of the four vaccine strains 28 days after IIV4 vaccination; (2) immune response measured by anti-pneumococcal antibody concentrations for each of six pneumococcal serotypes (1, 3, 4, 7F, 14, 19A) 28 days after PPV23 vaccination.",
            "startOffset": 26479,
            "title": "Study objectives"
        },
        {
            "endOffset": 30623,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "In the post hoc analysis pooling participants \u226560 years of age from the co-administration and control groups, the immunogenicity of the IIV4 was similar in those with versus without comorbidities (Table 1).",
            "startOffset": 30417,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 21711,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 21710,
                    "startOffset": 21706
                }
            },
            "secId": "s0005",
            "sentence": "Administering the pneumococcal vaccine at an annual influenza vaccination visit has been suggested as a strategy to improve pneumococcal vaccine uptake [35].",
            "startOffset": 21554,
            "title": "Introduction"
        },
        {
            "endOffset": 36864,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 36863,
                    "startOffset": 36856
                },
                "b0205": {
                    "endOffset": 36863,
                    "startOffset": 36856
                },
                "b0210": {
                    "endOffset": 36863,
                    "startOffset": 36856
                }
            },
            "secId": "s0050",
            "sentence": "Previous studies found a reduced immune response to seasonal influenza vaccine in individuals with comorbidities, but these studies were too small to afford adequate precision in estimating immunogenicity, lacked adequately matched controls, and in one case reported incomplete serological data [40\u201342].",
            "startOffset": 36561,
            "title": "Discussion"
        },
        {
            "endOffset": 20336,
            "parents": [],
            "secId": "s0005",
            "sentence": "The recent introduction of quadrivalent influenza vaccines containing an additional B strain is expected to alleviate the problem of mismatching.",
            "startOffset": 20191,
            "title": "Introduction"
        },
        {
            "endOffset": 30198,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Again, seropositivity rate was high before vaccination (Fig. 3).",
            "startOffset": 30134,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 20917,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 20916,
                    "startOffset": 20912
                }
            },
            "secId": "s0005",
            "sentence": "In Europe, the most prevalent serotypes causing IPD that are present in both PPV23 and PCV13 are 3, 7F, 19A, 1, 14, 4, 19F, 23F, 9V, 6B, 18C and 5 in rank order [24].",
            "startOffset": 20751,
            "title": "Introduction"
        },
        {
            "endOffset": 23882,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Both vaccines and placebo were administered intramuscularly in a 0.5 mL dose.",
            "startOffset": 23805,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 27728,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Secondary objectives were to: (1) describe the safety and reactogenicity of the vaccines when co-administered or administered separately; (2) describe the immunogenicity of the IIV4 and PPV23 when co-administered or administered separately for all four influenza vaccine strains and 12 pneumococcal serotypes (1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) that are common to both the PPV23 and the PCV13.",
            "startOffset": 27318,
            "title": "Study objectives"
        },
        {
            "endOffset": 22130,
            "parents": [],
            "secId": "s0010",
            "sentence": "This was a phase III, randomized, observer-blind, multicenter trial in adults \u226550 years of age (NCT02218697).",
            "startOffset": 22021,
            "title": "Methods"
        },
        {
            "endOffset": 32289,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 32288,
                    "startOffset": 32284
                }
            },
            "secId": "s0050",
            "sentence": "We selected pneumococcal serotypes 1, 3, 4, 7F, 14 and 19A for assessment of the primary endpoint because these are shared by both PPV23 and PCV13 and are the most prevalent serotypes in Europe that are associated with invasive disease (accounting for approximately 40%) [24].",
            "startOffset": 32013,
            "title": "Discussion"
        },
        {
            "endOffset": 34334,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 34333,
                    "startOffset": 34329
                }
            },
            "secId": "s0050",
            "sentence": "Non-inferiority criteria were not achieved for influenza A/H3N2, although the authors concluded that this likely resulted from the high pre-vaccination antibody titers to A/H3N2 [38].",
            "startOffset": 34151,
            "title": "Discussion"
        },
        {
            "endOffset": 22803,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study was conducted at one center in Belgium and six centers in France during the 2014\u20132015 influenza season and included adults \u226550 years of age at risk of complications from influenza or pneumococcal infections who met their country\u2019s recommendations for vaccination (see Supplement).",
            "startOffset": 22513,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 19749,
            "parents": [],
            "secId": "s0005",
            "sentence": "Vaccination against both diseases is recommended in many countries for older adults and persons with underlying risk conditions.",
            "startOffset": 19621,
            "title": "Introduction"
        },
        {
            "endOffset": 24308,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The IIV4 (GSK, Dresden, Germany) contained 15 \u03bcg hemagglutinin (HA) of each of the four strains recommended by the World Health Organization for the Northern Hemisphere in the 2014\u20132015 influenza season: A/Christchurch/16/2010 (A/H1N1), A/Texas/50/2012 (A/H3N2), B/Brisbane/60/2008 (B/Victoria) and B/Massachusetts/2/2012 (B/Yamagata).",
            "startOffset": 23973,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 24538,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The PPV23 (Merck & Co Inc, Quebec, Canada) contained 25 \u00b5g each of 23 purified capsular polysaccharides from S. pneumoniae types 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F.",
            "startOffset": 24309,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 27318,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Non-inferiority criteria were met if the upper limit of the 95% confidence interval (CI) of the GMT or GMC ratio (control over co-administration) was \u22642.0 for: (1) each of the four influenza vaccine strains and (2) each of the six pneumococcal serotypes evaluated for the primary endpoint.",
            "startOffset": 27029,
            "title": "Study objectives"
        },
        {
            "endOffset": 37902,
            "parents": [],
            "secId": "s0050",
            "sentence": "Because frail elderly people tend to reside in a care facility (and are therefore not in an outpatient setting), they did not form part of the study population.",
            "startOffset": 37742,
            "title": "Discussion"
        },
        {
            "endOffset": 25230,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "SCR was defined as the percentage of participants with either (a) pre-vaccination reciprocal HI titer <1:10 and a post-vaccination reciprocal titer \u22651:40; or (b) pre-vaccination reciprocal titer \u22651:10 and at least a 4-fold increase in post-vaccination reciprocal titer.",
            "startOffset": 24961,
            "title": "Study endpoints"
        },
        {
            "endOffset": 19270,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 19269,
                    "startOffset": 19262
                },
                "b0090": {
                    "endOffset": 19269,
                    "startOffset": 19262
                },
                "b0095": {
                    "endOffset": 19269,
                    "startOffset": 19262
                },
                "b0100": {
                    "endOffset": 19269,
                    "startOffset": 19262
                }
            },
            "secId": "s0005",
            "sentence": "Seasonal epidemics of influenza and pneumococcal disease occur worldwide during the winter months in countries with a temperate climate, and several studies have demonstrated a temporal association between influenza and invasive pneumococcal disease (IPD) [17\u201320].",
            "startOffset": 19006,
            "title": "Introduction"
        },
        {
            "endOffset": 26460,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Serious adverse events (SAEs), potential immune-mediated diseases, and medically attended adverse events were recorded until the final study contact on Day 180.",
            "startOffset": 26300,
            "title": "Study endpoints"
        },
        {
            "endOffset": 29749,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "High prevaccination seropositivity rates were observed for all vaccine strains.",
            "startOffset": 29670,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 36971,
            "parents": [],
            "secId": "s0050",
            "sentence": "General (systemic) symptoms were similar in the co-administration and separate administration study groups.",
            "startOffset": 36864,
            "title": "Discussion"
        },
        {
            "endOffset": 28879,
            "parents": [],
            "secId": "s0035",
            "sentence": "Demographics were similar in both study groups; mean age was 68.3 years and most participants (97.9%) were of White Caucasian/European heritage (Table S1).",
            "startOffset": 28724,
            "title": "Results"
        },
        {
            "endOffset": 28515,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The safety analysis was based on the total vaccinated cohort (TVC) which included all vaccinated participants for whom safety data were available.",
            "startOffset": 28369,
            "title": "Statistics"
        },
        {
            "endOffset": 21310,
            "parents": [],
            "secId": "s0005",
            "sentence": "In general, industrialized countries recommend both influenza and pneumococcal vaccination in persons at higher risk of infection or complications and in all adults \u226565 years of age.",
            "startOffset": 21128,
            "title": "Introduction"
        },
        {
            "endOffset": 25684,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "For the PPV23, anti-pneumococcal antibody concentrations were determined by 22F-inhibition enzyme-linked immunosorbent assay (ELISA) for the 12 serotypes shared by PPV23 and PCV13: 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F.",
            "startOffset": 25452,
            "title": "Study endpoints"
        },
        {
            "endOffset": 35147,
            "parents": [],
            "secId": "s0050",
            "sentence": "In fact, approximately 85% of participants had at least one comorbidity.",
            "startOffset": 35075,
            "title": "Discussion"
        },
        {
            "endOffset": 30416,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Only one participant in the co-administration group and four in the control group had three or more comorbidities.",
            "startOffset": 30302,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 35809,
            "parents": [],
            "secId": "s0050",
            "sentence": "To obtain a group of sufficient size for a meaningful comparison of IIV4 immunogenicity in individuals with and without comorbidities, we conducted a post hoc analysis pooling data from the co-administration and separate administration study groups in participants \u226560 years of age.",
            "startOffset": 35527,
            "title": "Discussion"
        },
        {
            "endOffset": 23972,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The IIV4 was given in the dominant arm and the PPV23 and placebo in the non-dominant arm.",
            "startOffset": 23883,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 26085,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The following parameters were derived: (1) geometric mean concentration (GMC); (2) proportion of seropositive participants (concentration \u22650.05 \u00b5g/mL, the assay cut-off); (3) proportion of participants with concentration \u22650.2 \u00b5g/mL (the threshold for seroprotection at the population level); (4) proportion of participants with at least a 2-fold and 4-fold increase in post-vaccination concentration.",
            "startOffset": 25685,
            "title": "Study endpoints"
        },
        {
            "endOffset": 28723,
            "parents": [],
            "secId": "s0035",
            "sentence": "A total of 356 and 334 participants were included in the TVC and PPC, respectively (Fig. S1).",
            "startOffset": 28630,
            "title": "Results"
        },
        {
            "endOffset": 23645,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Treatment allocation was performed at the investigator site using a central randomization system on internet (SBIR).",
            "startOffset": 23529,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 37507,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 37506,
                    "startOffset": 37502
                }
            },
            "secId": "s0050",
            "sentence": "A previous study also reported a higher proportion of participants with pain on co-administration of IIV4 and PPV23 in different arms compared with separate administration [37].",
            "startOffset": 37330,
            "title": "Discussion"
        },
        {
            "endOffset": 34150,
            "parents": [],
            "secId": "s0050",
            "sentence": "However, non-inferiority criteria were achieved for all 13 pneumococcal serotypes with the exception of 19F.",
            "startOffset": 34042,
            "title": "Discussion"
        },
        {
            "endOffset": 19907,
            "parents": [],
            "secId": "s0005",
            "sentence": "Until recently, most influenza vaccine programs used a trivalent influenza vaccine (TIV) containing two influenza A strains (H1N1 and H3N2) and one B strain.",
            "startOffset": 19750,
            "title": "Introduction"
        },
        {
            "endOffset": 29669,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "The IIV4 was immunogenic against all four vaccine strains in terms of GMT (Fig. 2), SPR, SCR and MGI (Table S3).",
            "startOffset": 29557,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 31338,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "SAEs occurred in 4.0% and 6.1% of participants in the co-administration and control groups, respectively; none were considered related to vaccination (Table S5).",
            "startOffset": 31177,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 28622,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The calculations of study power and the GMT (IIV4), GMC (PPV23) and ratios are described in the Supplement.",
            "startOffset": 28515,
            "title": "Statistics"
        },
        {
            "endOffset": 35414,
            "parents": [],
            "secId": "s0050",
            "sentence": "Only five individuals in the PPC had three or more comorbidities, so meaningful interpretation of immunogenicity in this group was not possible.",
            "startOffset": 35270,
            "title": "Discussion"
        },
        {
            "endOffset": 20190,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 20189,
                    "startOffset": 20182
                },
                "b0115": {
                    "endOffset": 20189,
                    "startOffset": 20182
                }
            },
            "secId": "s0005",
            "sentence": "Suboptimal vaccine protection occurs when the predominant circulating influenza B virus is from the alternate lineage to the B strain contained in the vaccine [22,23].",
            "startOffset": 20023,
            "title": "Introduction"
        },
        {
            "endOffset": 33201,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 33200,
                    "startOffset": 33196
                }
            },
            "secId": "s0050",
            "sentence": "In a study of adults with chronic respiratory disease who received TIV and PPV23, there was no difference between administration groups in titers of influenza or pneumococcal (serotypes 4, 6B, 9V, 14, 18C, 19F and 23F) antibodies [36].",
            "startOffset": 32966,
            "title": "Discussion"
        },
        {
            "endOffset": 37329,
            "parents": [],
            "secId": "s0050",
            "sentence": "However, grade 3 pain was rare.",
            "startOffset": 37298,
            "title": "Discussion"
        },
        {
            "endOffset": 29956,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "GMTs were higher in participants 50 to <60 years of age versus those \u226560 years of age (Fig. 2).",
            "startOffset": 29861,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 37297,
            "parents": [],
            "secId": "s0050",
            "sentence": "Pain was more common with both the IIV4 and PPV23 when co-administered than when administered separately, despite the vaccines being administered in different arms.",
            "startOffset": 37133,
            "title": "Discussion"
        },
        {
            "endOffset": 29860,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Postvaccination, there was a similar immune response in the co-administration and the control groups (Fig. 2).",
            "startOffset": 29750,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 24925,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "For the IIV4, the following parameters were derived from hemagglutination inhibition (HI) titers: (1) geometric mean titer (GMT); (2) seroconversion rate (SCR); (3) seroprotection rate (SPR); (4) mean geometric increase (MGI).",
            "startOffset": 24699,
            "title": "Study endpoints"
        },
        {
            "endOffset": 35947,
            "parents": [],
            "secId": "s0050",
            "sentence": "The analysis showed no consistent difference in the immunogenicity of the IIV4 in people with comorbidities versus without comorbidities.",
            "startOffset": 35810,
            "title": "Discussion"
        },
        {
            "endOffset": 19621,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 19620,
                    "startOffset": 19616
                }
            },
            "secId": "s0005",
            "sentence": "Influenza A infection triggers dispersal of virulent pneumococci, and this is associated with upregulation of genes involved in carbohydrate metabolism and bacteriocin production, as well as downregulation of genes associated with colonization [21].",
            "startOffset": 19372,
            "title": "Introduction"
        },
        {
            "endOffset": 23422,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Minimization in the randomization algorithm accounted for age, history of pneumococcal vaccination, history of influenza vaccination, comorbidities (none, one, two or at least three underlying comorbidities per participant) and country, with an equal weight for all the factors.",
            "startOffset": 23144,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 34041,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 34040,
                    "startOffset": 34036
                }
            },
            "secId": "s0050",
            "sentence": "A study of co-administration versus separate administration of TIV and PCV13 in adults \u226565 years of age showed a similar immune response to TIV regardless of administration regimen, but a lower immune response to PCV13 when administered concomitantly compared with when administered alone [38].",
            "startOffset": 33747,
            "title": "Discussion"
        },
        {
            "endOffset": 31049,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Pain occurred in more participants in the co-administration group than in the control group: 33.5% versus 15.8%, respectively, after IIV4 administration and 43.9% versus 35.6%, respectively, after PPV23 administration (Table 2).",
            "startOffset": 30821,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 23528,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The minimization algorithm was used to balance the prevalence of these factors within each vaccine group.",
            "startOffset": 23423,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 38652,
            "parents": [],
            "secId": "s0050",
            "sentence": "In conclusion, the study demonstrated immunological non-inferiority of co-administration of the IIV4 and PPV23 compared with separate administration in adults \u226550 years of age, indicating that the vaccines can be co-administered at different injection sites without reducing immunogenicity against influenza and pneumococcal illness.",
            "startOffset": 38319,
            "title": "Discussion"
        },
        {
            "endOffset": 21443,
            "parents": [],
            "secId": "s0005",
            "sentence": "It is recommended that the influenza vaccine is administered annually and the pneumococcal vaccine is administered every 5\u201310 years.",
            "startOffset": 21311,
            "title": "Introduction"
        },
        {
            "endOffset": 19006,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 19005,
                    "startOffset": 18992
                },
                "b0060": {
                    "endOffset": 19005,
                    "startOffset": 18992
                },
                "b0075": {
                    "endOffset": 19005,
                    "startOffset": 18992
                },
                "b0080": {
                    "endOffset": 19005,
                    "startOffset": 18992
                }
            },
            "secId": "s0005",
            "sentence": "Risk factors for pneumococcal disease are similar to those of influenza [10,12,15,16].",
            "startOffset": 18920,
            "title": "Introduction"
        },
        {
            "endOffset": 38729,
            "parents": [],
            "secId": "s0050",
            "sentence": "In our study, comorbidities had no impact on the immunogenicity of the IIV4.",
            "startOffset": 38653,
            "title": "Discussion"
        },
        {
            "endOffset": 31088,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "The incidence of grade 3 pain was low.",
            "startOffset": 31050,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 22013,
            "parents": [],
            "secId": "s0005",
            "sentence": "In the present phase III, non-inferiority study, we compared the immunogenicity and safety of co-administration of GSK\u2019s inactivated quadrivalent influenza vaccine (IIV4) with PPV23 versus separate administration in adults \u226550 years of age at risk of complications of influenza or pneumococcal disease.",
            "startOffset": 21711,
            "title": "Introduction"
        },
        {
            "endOffset": 38862,
            "parents": [],
            "secId": "s0050",
            "sentence": "Co-administration of PPV23 at the annual influenza vaccination visit may improve convenience and result in increased vaccine uptake.",
            "startOffset": 38730,
            "title": "Discussion"
        },
        {
            "endOffset": 18523,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 18522,
                    "startOffset": 18515
                },
                "b0030": {
                    "endOffset": 18522,
                    "startOffset": 18515
                },
                "b0035": {
                    "endOffset": 18522,
                    "startOffset": 18515
                },
                "b0040": {
                    "endOffset": 18522,
                    "startOffset": 18515
                }
            },
            "secId": "s0005",
            "sentence": "Older adults and persons with underlying conditions such as diabetes and chronic heart, lung, liver or kidney disease are at particular risk of developing severe complications following influenza infection [1,6\u20138].",
            "startOffset": 18309,
            "title": "Introduction"
        },
        {
            "endOffset": 32012,
            "parents": [],
            "secId": "s0050",
            "sentence": "The study met its co-primary objectives by demonstrating non-inferiority of co-administration of the IIV4 and PPV23 versus separate administration, with the upper limit of the 95% CI of the GMT or GMC ratio (separate administration over co-administration) being \u22642.0 for each of the four influenza vaccine strains and each of the pre-selected six pneumococcal serotypes evaluated as a primary endpoint.",
            "startOffset": 31610,
            "title": "Discussion"
        },
        {
            "endOffset": 37132,
            "parents": [],
            "secId": "s0050",
            "sentence": "Few participants experienced a serious adverse event.",
            "startOffset": 37079,
            "title": "Discussion"
        },
        {
            "endOffset": 25452,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "MGI was defined as the geometric mean of the within-subject ratios of the post-vaccination/pre-vaccination reciprocal HI titer.",
            "startOffset": 25325,
            "title": "Study endpoints"
        },
        {
            "endOffset": 34671,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 34670,
                    "startOffset": 34666
                }
            },
            "secId": "s0050",
            "sentence": "In another study of TIV and PCV13 in healthy adults 50\u201359 years of age, the immune response to the TIV was robust and non-inferior when administered concomitantly with the PCV13 compared with when administered separately, but the immune response to the PCV13 was lower when administered concomitantly with TIV for all 13 serotypes [39].",
            "startOffset": 34335,
            "title": "Discussion"
        },
        {
            "endOffset": 23017,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Participants were randomized 1:1 into a co-administration group or a separate administration (control) group.",
            "startOffset": 22908,
            "title": "Participants, study design and vaccines"
        },
        {
            "endOffset": 35269,
            "parents": [],
            "secId": "s0050",
            "sentence": "GMTs for each influenza vaccine strain were similar in participants with one comorbidity compared with two comorbidities.",
            "startOffset": 35148,
            "title": "Discussion"
        },
        {
            "endOffset": 24698,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Immunogenicity was evaluated pre-vaccination and 28 days after the administration of each vaccine (see Supplement).",
            "startOffset": 24583,
            "title": "Study endpoints"
        },
        {
            "endOffset": 38319,
            "parents": [],
            "secId": "s0050",
            "sentence": "High seropositivity was to be expected in an older population with substantial previous exposure to influenza and pneumococcal vaccinations as recommended by the French and Belgian health authorities.",
            "startOffset": 38119,
            "title": "Discussion"
        },
        {
            "endOffset": 20750,
            "parents": [],
            "secId": "s0005",
            "sentence": "Pneumococcal conjugate vaccines have been developed more recently, and a 13-valent vaccine (PCV13) is now approved in some countries for the prevention of pneumonia and invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in adults.",
            "startOffset": 20466,
            "title": "Introduction"
        },
        {
            "endOffset": 30301,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Immunogenicity of the IIV4 was similar in those with one, two or at least three comorbidities (Fig. 4).",
            "startOffset": 30198,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 18919,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 18918,
                    "startOffset": 18911
                },
                "b0055": {
                    "endOffset": 18918,
                    "startOffset": 18911
                },
                "b0060": {
                    "endOffset": 18918,
                    "startOffset": 18911
                },
                "b0065": {
                    "endOffset": 18918,
                    "startOffset": 18911
                },
                "b0070": {
                    "endOffset": 18918,
                    "startOffset": 18911
                }
            },
            "secId": "s0005",
            "sentence": "Morbidity and mortality associated with pneumococcal disease are high even in the developed world [10\u201314].",
            "startOffset": 18813,
            "title": "Introduction"
        },
        {
            "endOffset": 37741,
            "parents": [],
            "secId": "s0050",
            "sentence": "A key strength was that it recruited participants in an outpatient setting (via advertisements in clinics and hospitals) so both healthy people and people with comorbidities were enrolled.",
            "startOffset": 37553,
            "title": "Discussion"
        },
        {
            "endOffset": 28368,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The primary immunogenicity analysis was based on the per-protocol cohort (PPC) which included all participants who met eligibility criteria, complied with the protocol and their vaccine schedule, and had post-vaccination immunogenicity results against at least one antigen contained in the study vaccine.",
            "startOffset": 28064,
            "title": "Statistics"
        },
        {
            "endOffset": 19371,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 19370,
                    "startOffset": 19366
                }
            },
            "secId": "s0005",
            "sentence": "Additionally, influenza A infection has been shown to promote the pathogenicity of pneumococci [21].",
            "startOffset": 19271,
            "title": "Introduction"
        }
    ],
    "docId": "S0264410X17312288",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "opokua.ofori-anyinam@gsk.com",
                "first": "Opokua",
                "initial": "O.",
                "last": "Ofori-Anyinam"
            },
            {
                "email": "geert.lerouxroels@ugent.be",
                "first": "Geert",
                "initial": "G.",
                "last": "Leroux-Roels"
            },
            {
                "email": "Mamadou.X.Drame@gsk.com",
                "first": "Mamadou",
                "initial": "M.",
                "last": "Drame"
            },
            {
                "email": "annelies.aerssens@uzgent.be",
                "first": "Annelies",
                "initial": "A.",
                "last": "Aerssens"
            },
            {
                "email": "Cathy.Maes@uzgent.be",
                "first": "Cathy",
                "initial": "C.",
                "last": "Maes"
            },
            {
                "email": "Arshad.A.Amanullah@gsk.com",
                "first": "Arshad",
                "initial": "A.",
                "last": "Amanullah"
            },
            {
                "email": "Anne.E.Schuind@gsk.com",
                "first": "Anne",
                "initial": "A.",
                "last": "Schuind"
            },
            {
                "email": "pingli.rtp@hotmail.com",
                "first": "Ping",
                "initial": "P.",
                "last": "Li"
            },
            {
                "email": "Varshakjain@gmail.com",
                "first": "Varsha K.",
                "initial": "V.K.",
                "last": "Jain"
            },
            {
                "email": "innisb00@gmail.com",
                "first": "Bruce L.",
                "initial": "B.L.",
                "last": "Innis"
            }
        ],
        "doi": "10.1016/j.vaccine.2017.09.012",
        "firstpage": "6321",
        "issn": "0264410X",
        "keywords": [
            "Co-administration",
            "Comorbidity",
            "Influenza",
            "Non-inferiority",
            "Pneumococcal",
            "Vaccine"
        ],
        "lastpage": "6328",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults \u226550 years of age: Results from a phase III, randomized, non-inferiority trial"
    }
}